Serum neopterin levels in patients with brucellosis

dc.contributor.authorAkbulut, HH
dc.contributor.authorCelik, I
dc.contributor.authorAkbulut, A
dc.contributor.authorYuce, P
dc.contributor.authorKiliç, SS
dc.date.accessioned2026-08-12T17:44:27Z
dc.date.issued2005
dc.departmentFırat Üniversitesi
dc.description13th European Congress of Clinical Microbiology and Infectious Diseases -- MAY 10-13, 2003 -- GLASGOW, SCOTLAND
dc.description.abstractObjectives. The aim of this study was to evaluate the importance of neopterin levels in brucellosis and its alterations with treatment. Methods. Thirty patients who had positive clinical findings, Brucella standard tube agglutination tests and/or positive blood culture were included in the study. The control group was composed of 30 healthy subjects. Neopterin (NPT) levels were measured by ELISA according to the protocol of manufacturer. Results. Mean NPT levels were 54.15 +/- 33.7 nmol/l in study groups and 8.75 +/- 2.48 nmol/l in controls (P<0.001). It was determined that NPT levels measured at the time of admission of the patients had a linear correlation between the duration of complaint (r=0.560, P=0.001). White the mean NPT levels in patients with complaints of over 30 days were 79.07 +/- 34.9 nmol/l and it was 39.71 +/- 23.4 nmol/l in the patients with complaints of less than or equal to 30 days (P=0.002). NPT values measured after treatment (20.48 +/- 25.6) was determined tower by statistical means than the values measured before treatment (54.15 +/- 33.7, P=0.0001). The NPT levels of patients with positive blood culture (75.56 +/- 33.6) were higher than those of with negative blood cultures (32.72 +/- 15.2, P=0.001). Conclusion. It was concluded that the NPT levels were higher in patients with brucellosis. In addition, it was found that the levels of NPT were higher in nonresponding patients than responded to the brucellosis treatment. It was thought that monitoring NPT levels could be useful for the extent and activity of the disease. (C) 2004 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
dc.description.sponsorshipBelgian Fonds Format Rech Ind Agr,Belgian Fonds Natl Rech Sci,Belgian Fonds Rech Sci Med
dc.identifier.doi10.1016/j.jinf.2004.10.015
dc.identifier.endpage286
dc.identifier.issn0163-4453
dc.identifier.issn1532-2742
dc.identifier.issue4
dc.identifier.orcid0000-0002-2604-3776
dc.identifier.pmid16291280
dc.identifier.scopus2-s2.0-28044458784
dc.identifier.scopusqualityQ1
dc.identifier.startpage281
dc.identifier.urihttps://doi.org/10.1016/j.jinf.2004.10.015
dc.identifier.urihttps://hdl.handle.net/11508/60256
dc.identifier.volume51
dc.identifier.wosWOS:000233650500002
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherW B Saunders Co Ltd
dc.relation.ispartofJournal of Infection
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectbrucellosis
dc.subjectneopterin levels
dc.subjectmonitoring therapy
dc.titleSerum neopterin levels in patients with brucellosis
dc.typeConference Object

Dosyalar